Results 171 to 180 of about 22,058 (247)

Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications

Danny CHINCHILLA-CÁRDENAS, Juan Sebastian Cruz-Méndez, Julieth Michel Petano-Duque, Ramón Ovidio García, Lyda R. Castro, María Jesús Lobo‐Castañón, Giovanni Orlando Cancino Escalante   +6 more
openalex   +1 more source

Search for the Exotic State $U(3100)$ in SELEX

, 2003
E. Blanco-Covarrubias
openalex   +2 more sources

Reagentless Real-Time ATP Monitoring with New DNA Aptamers. [PDF]

Small
Bacon A, Alkhamis O, Byrd C, Perry J, Canoura J, Xiao Y.   +5 more
europepmc   +1 more source

Aptamers as emerging tools for plant disease management: From biosensing to active modulation. [PDF]

iScience
Liu F, Zhang Y, Wei Z, Wu H, Jia Y, Li X.   +5 more
europepmc   +1 more source

Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX

Sonja Korhonen, Katja Stenberg, Umair Seemab, Piia Bartos, Katariina Mäkiniemi, Jørgen Kjems, Daniel M. Dupont, Astrid Subrizi   +7 more
openalex   +1 more source

Aptamer Engineering: Strategies for Discovering Functional Nucleic Acids for Next-Generation Diagnostics and Biosensing. [PDF]

Adv Sci (Weinh)
Nguyen JVL, Meziadi A, Brunner C, McKeague M, Malic L, Tabrizian M.   +5 more
europepmc   +1 more source

Gold Nanoparticles as a Platform for Small Molecule SELEX

, 2017
McKenzie Smith
openalex   +2 more sources

AP1 is a pioneer transcription factor that programmes cell fate through MADS-domain protein tetramerisation. [PDF]

Genome Biol
Xu X, Neumann M, Carew F, Chen P, Braeuning C, Zubieta C, Muino JM, Smaczniak C, Kaufmann K.   +8 more
europepmc   +1 more source

Quantifying transcription factor specificity with advanced DNA universal microarrays featuring long and modified binding sites. [PDF]

Nucleic Acids Res
Bayer Y, O'Hagan MP, Miodownik I, Afek A.   +3 more
europepmc   +1 more source